Phase III, randomized, multicentre trial of maintenance biotherapy with interleukin-2 (IL-2) and interferon-alpha (IFN) for metastatic renal cell cancer (RCC)Rodolfo Passalacqua, Caterina Caminiti, Camillo Porta et al.|Journal of Clinical Oncology|2005Cited by 3
Integrating Nutrition and Exercise to Mitigate Cardiometabolic Risk and Enhance Outcomes in Lung Cancer During the Era of Immunotherapy and Targeted TherapyGiuseppina Gallucci, Luigi Tarantini, Alessandro Inno et al.|Nutrients|2026Cited by 0